Global PMMA Intraocular Lens Market Size By Type (Hydrophilic, Hydrophobic), By Application (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2023 to 2032

The Global PMMA Intraocular Lens Market was valued at USD 1.04 billion in 2023 and is expected to reach USD 1.61 billion by 2031, growing at a CAGR of 5.6% during the forecast period from 2023 to 2031. The growth of this market is driven by the increasing global burden of cataracts, especially in aging populations, along with the cost-effectiveness and biocompatibility of PMMA (Polymethyl methacrylate) intraocular lenses. Despite the increasing use of foldable lenses, PMMA lenses continue to be widely adopted in developing countries due to their affordability and proven clinical efficacy.

Drivers

1. High Prevalence of Cataract and Vision Impairment:

The global rise in cataract cases, particularly in elderly populations, is a significant driver of the PMMA intraocular lens market. PMMA lenses are still extensively used in cataract surgeries in cost-sensitive regions due to their lower production costs and established safety profile.

2. Economic Viability in Emerging Markets:

In regions with limited access to advanced healthcare infrastructure, PMMA IOLs are preferred over foldable lenses for their low cost and ease of manufacture. Governments and NGOs in countries across Asia, Africa, and Latin America are increasingly supporting cataract surgery initiatives, bolstering market demand.

3. Proven Durability and Optical Clarity:

PMMA IOLs offer long-term stability, excellent optical clarity, and minimal chances of posterior capsule opacification (PCO), contributing to their continued usage in ophthalmic procedures.

Restraints

1. Lack of Flexibility and Surgical Limitations:

Unlike foldable lenses, PMMA IOLs require larger surgical incisions for implantation, leading to longer healing times and higher risks of surgical complications. This limits their usage in high-income markets favoring minimally invasive procedures.

2. Technological Shift Toward Foldable IOLs:

Technological advancements in hydrophobic and hydrophilic foldable lenses, which allow micro-incision surgeries, are gradually reducing the adoption of rigid PMMA lenses, especially in developed nations.

Opportunity

1. Expansion in Low-to-Middle Income Countries (LMICs):

There is substantial growth potential in LMICs where cataract remains a leading cause of blindness and healthcare affordability is a concern. Strategic collaborations with local healthcare providers and NGOs can help expand market reach.

2. Customization and Mass Cataract Surgery Programs:

Ongoing development of customized PMMA IOLs and their integration into large-scale cataract surgery campaigns by organizations like WHO and IAPB offer new avenues for market expansion.

Market by System Type Insights

Based on product type, Monofocal PMMA Intraocular Lenses held the largest market share in 2023. Their simple design, high availability, and lower cost make them the go-to choice for standard cataract surgeries in most developing countries. However, Multifocal PMMA IOLs are gaining traction in specific niche applications, particularly where patients demand improved visual outcomes at multiple distances.

Market by End-use Insights

Public hospitals and ophthalmology clinics represented the dominant end-user segment in 2023, driven by government-backed cataract elimination programs. These institutions prioritize affordability and reliability, favoring PMMA lenses over premium alternatives. Meanwhile, non-profit eye care centers such as those operated by NGOs have shown rapid adoption, primarily due to cost-efficient bulk procurement models.

Market by Regional Insights

Asia-Pacific dominated the global PMMA intraocular lens market in 2023, accounting for over 50% of the total share, led by India, China, and Indonesia—countries with high cataract prevalence and active government initiatives. Africa and Latin America are emerging as high-growth regions, owing to increasing healthcare access and global efforts toward vision restoration. North America and Europe are witnessing declining use of PMMA IOLs due to patient preference for foldable alternatives.

Competitive Scenario

Key players in the Global PMMA Intraocular Lens Market include Aurolab, Appasamy Associates, Rayner Intraocular Lenses Limited, Biotech Healthcare, Care Group, Hoya Corporation, HumanOptics AG, and Omni Lens Pvt. Ltd. These companies are focusing on enhancing lens material purity, reducing postoperative complications, and expanding distribution in underserved markets.

Scope of Work – Global PMMA Intraocular Lens Market

Report Metric Details

Market Size (2023) USD 1.04 Billion

Projected Market Size (2031) USD 1.61 Billion

CAGR (2023–2031) 5.6%

Market Segments By System Type (Monofocal, Multifocal), End-use (Hospitals, Clinics, NGOs), Region

Growth Drivers High prevalence of cataracts, affordability in emerging markets, proven safety and durability